Skip to main content
Novartis Home

Language & Country Selector for Desktop

language-selector-globe Global | en

Choose Location

  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | en
Sandoz | en
Novartis Foundation | en
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Global

Choose Location

International Americas Asia Pacific Europe Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Global | en
Sandoz | en
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Board of Directors 
        • Joerg Reinhardt 
        • Simon Moroney 
        • Nancy C. Andrews 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Charles L. Sawyers 
        • William T. Winters 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 
        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Klaus Moosmayer 
        • Marie-France Tschudin 
        • Lutz Hegemann 
        • Kees Roks 
        • Richard Saynor 
        • Michael Willi 
      • Strategy 
        • People and Culture 
        • Data and Digital 
      • Products 
      • Innovative Medicines 
      • Sandoz 
      • Diversity, Equity & Inclusion 
        • Equity 
        • Diversity, Equity & Inclusion Governance and Community 
        • Inclusivity 
        • Parental Leave 
        • Society 
      • Manufacturing 
      • Quality 
        • Audit program 
        • Novartis Quality Management System (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Awards and Recognition 
      Male scientist in lab

      About

      Learn about how Novartis is organized and our strategy, vision and mission. Meet our people and read about our commitments to diversity, equity and inclusion. Explore our history which goes back more than 250 years.

    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Patient Organization Funding 
      • Stories: Patients Perspectives 
      Couple holding hands

      Patients and Caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare Professionals 
      • Medical Congresses and Events 
        • Abstract summaries for EULAR 
        • Abstract summaries for ACR 
      • Products 
      • Novartis Pipeline 
      • Managed Access Programs 
        • Novartis Gene Therapies Managed Access Program 
      • Novartis External Funding 
      • Healthcare Professional Resources by Country 
      • Investigator-Initiated Trials / Studies 
      • Transparency and Disclosure 
      • Novartis Medical Information 
        • Submit medical enquiry 
      Doctor

      Healthcare Professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research & Development 
      • Novartis Institutes for BioMedical Research 
        • Collaborations 
        • NIBR Global Scholars Program 
      • Technology Platforms 
        • Radioligand Therapy 
        • Gene Therapy 
        • Cell Therapy 
      • Research Disease Areas 
        • Cardiovascular and metabolic disease research at Novartis 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
        • Ophthalmology research at Novartis 
      • Research Locations 
      • Novartis Pipeline 
      • Translational Medicine 
      • Research Collaborations 
      • Open Source Science 
      • Stories from our Labs 
      Scientists conducting innovative research experiments

      Research & Development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments. Learn about our innovation engine, the Novartis Institutes for BioMedical Research (NIBR) and explore our research areas, technology platforms and pipeline.
       

    • ESG 
      • Access 
        • Creating sustainable business models 
        • Value-Based Pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis Access Principles 
        • Novartis Oncology Access 
        • Patents and Licensing 
      • Ethics, Risk and Compliance 
        • Ethical Behavior 
        • Compliance 
        • Human Rights 
        • Learning and Engagement 
        • Risk management 
      • Environmental Sustainability 
        • Climate 
        • Waste 
        • Water 
      • Global Health 
        • Anti-Microbial Resistance (AMR) 
        • Avoidable Blindness 
        • Chagas Disease 
        • Leprosy 
        • Malaria 
        • Sickle Cell Disease (SCD) 
        • Novartis Foundation 
      • Diversity, Equity & Inclusion 
      • Reporting 
        • ESG Rating Performance 
        • Codes, Policies and Guidelines 
        • Materiality Assessment 
        • Transparency and Disclosure 
        • Targets 
        • Positions 
      • ESG Index 
      Young patients waiting outside an hospital in Rwanda

      Environmental, Social and Governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 
      • Event Calendar 
      • Financial Data 
        • Novartis Annual Results 
        • Novartis Quarterly Results 
        • Novartis SEC Filings 
        • Product Sales 
        • Fixed-Income Securities 
        • Expected Currency Impact 
      • Share Data & Analysis 
        • Share Monitor 
        • Dividend Information 
        • Share Ownership 
        • Share Overview 
        • Return On Investment Calculator 
      • Shareholder Information 
        • General Meetings 
        • American Depository Receipts (ADR) 
        • Share Buy-Back 
        • Frequently Asked Questions 
      • Company Overview 
        • Corporate Governance 
      • Novartis Annual Reporting Suite 
        • Reporting Archive 
        • Publications Order Form 
      • ESG 
      Hands marking a test tube

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 
      • News Archive  
      • Media Library  
      • Stories 
      • Subscribe 
      People at the table with screens

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers 
      • Career Search 
      • Benefits & Rewards 
      • Career Programs 
        • Community Exploration & Learning Lab (CELL) 
        • Postdoc Program 
      • Early Careers 
        • Careers in Data, Digital & Information Technology (IT) 
        • Careers in Manufacturing and Supply 
        • US NIBR Internship Programs 
      • Personal Growth 
      • Wellbeing 
      Close-up portrait of a scientist in Cambridge, USA

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical Trials 
      doctor taking the blood pressure of her patient

      Clinical Trials

      Find recruiting clinical trials and learn more about how to participate or work with Novartis on clinical studies. Read about our clinical trials transparency initiatives.

    • Partnering 
      Business people working in a dark room

      Partnering

      Learn about our approach to partnering which combines capabilities, collaboration and culture.

    • Supplier Portal 
      Group of business people in a meeting area

      Supplier Portal

      Practical information and resources for suppliers around the world.

    • Report side effects 
    • Contacts 
      Office Cubicle

      Contacts

      Get in touch.

    engineers walking in packaging facility big_0

    Home

    Welcome to Novartis where we are reimagining medicine to improve and extend people’s lives.

Stories

Story Navigation
  • All Topics
  • Discovery
  • From Our Labs
  • Patient Perspectives
  • Access to Healthcare
  • People & Culture
icon
  • Infant patient being held by a healthcare professional during examination
    Access to Healthcare
    Access to HealthcareClinical ResearchEthical BusinessMedicine Safety
    Dec 16, 2022
    Compassionate use: Providing access to much needed treatments

    What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.

    Access to Healthcare
  • NITD samples
    Access to Healthcare
    Access to HealthcareClinical ResearchDrug DevelopmentInfectious DiseasesTropical Diseases
    Jun 21, 2022
    Renewing our commitment to neglected tropical disease and malaria elimination

    Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.

    Access to Healthcare
  • A sickle cell screening program for newborns at Kumasi General Hospital
    Access to Healthcare
    Access to HealthcareAfricaChildren's HealthNovartis Access
    Jun 16, 2022
    Sickle cell screening urged for newborns in Africa

    Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.

    Access to Healthcare
  • Elder man with glasses smiling
    Access to Healthcare
    Access to HealthcareCancerOncologySocial CommitmentTargeted Therapy
    Jun 7, 2022
    Prostate Cancer: A collective commitment to serving underserved communities

    Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.

    Access to Healthcare
  • Team of doctors in a patient's hospital room
    Access to Healthcare
    Access to HealthcareCancerNovartis AccessSocial Commitment
    May 19, 2022
    Boosting access to cancer care where it’s needed most

    Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.

    Access to Healthcare
  • Thierry Diagana, Head of the Novartis Institute for Tropical Diseases (NITD)
    Access to Healthcare
    Access to HealthcareInfectious DiseasesMalariaMedical InnovationsTropical Diseases
    Apr 7, 2022
    Staying one step ahead of the malaria parasite

    Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.

    Access to Healthcare
  • Stephanie Moquin, a post-doc in the Dengue team, works on expressing proteins in a specialized lab at the Novartis research campus in Emeryville.
    Access to Healthcare
    Chronic IllnessEnvironmental SustainabilityInfectious DiseasesMalariaNovartis Institutes for BioMedical Research
    Apr 4, 2022
    Tackling the health toll of climate change
    Access to Healthcare
  • Marie-France Tschudin, President of Novartis Pharmaceuticals
    Access to Healthcare
    Access to HealthcareCardiovascular DiseaseHeart DiseaseNovartis Access
    Mar 1, 2022
    Prioritizing the needs of patients
    Access to Healthcare
  • Charlotte Curtis portrait
    Access to Healthcare
    Access to HealthcareDisease AwarenessGenetic DiseaseLiving With DiseasePatient Voices
    Nov 1, 2021
    Breaking down barriers for patients with sickle cell disease

    One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.

    Access to Healthcare
  • john tsai qna hero
    Access to Healthcare
    Drug DevelopmentInnovationWorking at Novartis
    Nov 2, 2021
    To make a difference, start with patients

    John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

    Access to Healthcare
  • Character depiction of MDS with floating red blood cells all around.
    Access to Healthcare
    CancerDisease AwarenessFuture of HealthcareOncologyPatient Education
    Oct 25, 2021
    Demystifying the science of myelodysplastic syndromes

    Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.

    Access to Healthcare
  • Portrait of two chinese women holding an umbrella
    Access to Healthcare
    DigitalReimagine MedicineCardiovascular DiseaseFuture of HealthcareAccess to Healthcare
    Oct 6, 2021
    Expanding a new digital healthcare solution across chronic heart disease management

    More than 100,000 patients with heart failure in China are using our new AI-enabled platform, AI Nurse, to manage their condition and aim for better health.

    Access to Healthcare

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • › Next page

Novartis

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • Researchers
  • Job Seekers
  • Journalists
  • Investors
  • Partners
  • Suppliers
Topics
  • Clinical Trials
  • ESG
  • SpeakUp
Explore
  • Stories
  • Diseases
  • Locations
  • Products
  • Novartis Pipeline
Novartis companies
  • Sandoz
  • Advanced Accelerator Applications
  • Gyroscope Therapeutics
Footer Bottom
© 2023 Novartis AG
  • Terms of Use
  • Privacy
  • Contacts
  • Cookie Settings
  • Site Map
  • Web Accessibility
  • Open Source
Novartis Site Directory
This site is intended for a global audience